Press Release

PhRMA Statement on Surgeon General Nominee

PhRMA July 31, 2009

Washington, D.C. (July 13, 2009) — Pharmaceutical Research and Manufacturers of America (PhRMA) President Billy Tauzin issued the following statement today regarding the nomination of Dr. Regina Benjamin to the role of surgeon general:

“Dr. Regina Benjamin has long been a champion of providing health care to those who are struggling. Now, as we collectively move toward comprehensive health care reform, Dr. Benjamin’s experience as a doctor and a clinic administrator will be immensely valuable in working to ensure that all Americans have access to quality health care coverage.

“Dr. Benjamin has been aggressive throughout her career in advocating prevention of illness and in working to eliminate troubling disparities in health care access, quality and outcomes. In a country where 75 cents out of every health care dollar go toward treating chronic diseases that may be mitigated through preventive care – some of which are especially common to certain minority populations – this commitment is undeniably important.

“She has been a strong advocate for the uninsured, providing care for free to those who could not afford it elsewhere. In fact, as evidence of her dedication to the uninsured and underinsured, Dr. Benjamin and her clinic staff have worked with the Partnership for Prescription Assistance several times in the past. Sponsored by America’s pharmaceutical research companies, the PPA is a national clearinghouse that provides patients with information about assistance programs that may help them get the medicines they need for free or nearly free.

“PhRMA has been pleased to work with Dr. Benjamin in the past through the PPA and we look forward to working with her in the future to improve access, treatment and care across the country.”


The Pharmaceutical Research and Manufacturers of America (PhRMA) represents the country’s leading pharmaceutical research and biotechnology companies, which are devoted to inventing medicines that allow patients to live longer, healthier, and more productive lives. PhRMA companies are leading the way in the search for new cures. PhRMA members alone invested an estimated $50.3 billion in 2008 in discovering and developing new medicines. Industry-wide research and investment reached a record $65.2 billion in 2008.

PhRMA Internet Address:

For information on how innovative medicines save lives, visit:

For information on the Partnership for Prescription Assistance, visit:

For more information on public health emergencies, visit

For information on the danger of imported drugs, visit: